Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer
Amanda Foskett, Christina Manley, Rebecca Naramore, Ira K Gordon, Bridget M Stewart, Chand Khanna The Oncology Service, LLC, Leesburg, VA, USA Abstract: Sorafenib is a multi-target small molecule inhibitor of the RAF kinase family and VEGFR-2/PDGFR. The U...
Main Authors: | Foskett A, Manley C, Naramore R, Gordon IK, Stewart BM, Khanna C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | Veterinary Medicine : Research and Reports |
Subjects: | |
Online Access: | https://www.dovepress.com/tolerability-of-oral-sorafenib-in-pet-dogs-with-a-diagnosis-of-cancer-peer-reviewed-article-VMRR |
Similar Items
-
Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
by: WU Lei, et al.
Published: (2018-04-01) -
Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression
by: Zou X, et al.
Published: (2021-05-01) -
Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
by: Agnieszka Karbownik, et al.
Published: (2020-06-01) -
TACE combined with sorafenib in treatment of advanced primary hepatocellular carcinoma: a report of one case achieving complete response
by: MA Jingfan, et al.
Published: (2016-01-01) -
Sorafenib-induced acute pancreatitis
by: Han-En Wang, et al.
Published: (2014-01-01)